Despite the growing variety of cannabis products—ranging from edibles and topicals to concentrates, beverages, and vape cartridges—cannabis flower remains a core component of patient treatment options. Its rapid onset of effects, versatility, and relatively low cost make it a preferred form for many patients, especially those managing chronic conditions.
Unlike processed products, flower offers flexibility. Patients can smoke or vaporize it for fast relief or use it as a base to make personalized tinctures or edibles at home. In this context, the ability to legally access cannabis flower becomes essential—not just for convenience but for ensuring comprehensive and inclusive medical cannabis programs.
Colombia Joins the Ranks of Countries Offering Medical Cannabis Flower Through Pharmacies
Colombia is set to take a significant step forward by authorizing pharmacies to dispense psychoactive cannabis flower to patients with a valid medical prescription. The change comes via a draft decree from the Ministry of Justice, signaling the country's evolving stance on medical cannabis access.
According to Colombia One, the decree would permit patients to obtain cannabis flower for smoking or vaporizing, provided they have a prescription for conditions such as:
-
Chronic pain
-
Sleep disorders
-
Parkinson’s disease
-
Multiple sclerosis
-
Other central nervous system conditions
This move brings Colombia closer to global leaders like Germany and Uruguay, where cannabis flower is already available in pharmacies under medical regulation.
A Long Road to Patient-Centered Reform
Colombia first legalized medical cannabis in 2016 and began permitting exports of cannabis-derived products in 2021. Since then, Colombian cannabis has been gaining ground internationally, thanks to its ideal growing conditions and competitive production costs.
Large-scale producers in Colombia can reportedly cultivate quality cannabis for as little as $0.10 USD per gram—an unmatched advantage that has positioned the country as a key global player in cannabis exports.
Now, for the first time, those same high-quality products will be available directly to Colombian patients through pharmacies, ensuring safe access within the country’s own borders.
Closing the Gap Between Production and Domestic Access
For decades, Colombian cannabis has been appreciated around the world—often in unregulated forms. With the upcoming regulatory shift, local patients will benefit from the same high-quality flower, legally and without fear of prosecution. It’s a long-overdue alignment between Colombia’s production capabilities and patient needs.
This reform not only marks progress for Colombia but could also serve as a model for other Latin American nations exploring how to balance export growth with domestic access. For a deeper look at how other countries in the region are adapting their cannabis frameworks, read our coverage of Lebanon’s evolving cannabis strategy.
